Emre Yucel

3 Questions 6 Answers 0 Followers

Questions related from Emre Yucel

How will the future of urologic research, specifically urologic epidemiology, take shape?

The NIDDK cancelled the 2nd UDA Webinar. On the other hand, the same NIDDK announced for a new grant structure. How will the future of urologic research, specifically urologic epidemiology, take...

12 December 2015 10,076 0 View

When is it a good time to consider relative risk reduction and when is it a good time for attributable risk reduction?

The above question is a prevalence question. If the prevalence of disease is high (and assuming that the disease is serious), we would consider ARR (=Risk in unexposed - Risk in treated ) versus...

05 May 2014 5,543 2 View

Why is it that clinicians should not offer the following agents for the prevention of CIPN to patients with cancer undergoing treatment with neurotox?

ic agents: Acetyll-L-Carnitine, Amifostin, Amitriptyline, CaMg for patients receiving oxaliplatin-based chemotherapy, Diethyldithio-carbamate (DDTC), Glutathione (GSH) for patients receiving...

04 April 2014 4,430 2 View